Public attitudes toward molecular farming in the UK

AgBioForum

Volumn 11, Issue 2, 2008, Pages 106-113

  Milne, Richard ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Molecular farming; Plant made pharmaceuticals; Public attitudes; Qualitative research; UK

Indexed keywords

EID: 58849105419     PISSN: None     EISSN: 1522936X     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Corr-Willbourn Research and Development. (2005, March 15). A Report on a deliberative public engagement exercise concerning the use of biotechnology in non-food agriculture for the agriculture and environment biotechnology commission (CWR&D Job No. 887). London: Agricultural and Environment Biotechnology Commission.
2. Daniell, H., Streatfield, S.J., & Wycoff, K. (2001). Medical molecular farming: Production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends in Plant Science, 6, 219-26.
3. Einsiedel, E.F., & Medlock, J.E. (2005). A public consultation on plant molecular farming. AgBioForum, 8(1), 26-32. Available on the World Wide Web: http://www.agbioforum.org.
4. Frewer, L., Howard, C., Hedderley, D., & Shepherd, R. (1997). 'Objection' mapping in determining group and individual concerns regarding genetic engineering. Agriculture and Human Values, 14, 67-79.
5. Gaskell, G., Allansdottir, A., Allum, N., Corchero, C., Fischler, C., et al. (2006, May). Europeans and biotechnology in 2005: Patterns and trends (Eurobarometer, 64.3). Brussels: European Commission's Directorate General for Research.
6. Hoban, T. (2004, May). Public attitudes towards agricultural biotechnology (ESA Working Paper No. 04-09). Rome, Italy: Agricultural and Development Economics Division, The Food and Agriculture Organization of the United Nations.
7. Jasanoff, S. (2005). Designs on nature: Science and democracy in Europe and the United States. Princeton, NJ: Princeton University Press.
8. Khan, M.E.; & Manderson, L. (1992). Focus groups in tropical diseases research. Health Policy and Planning, 7, 56-66.
9. Kirk, D., & Mcintosh, K. (2005). Social acceptance of plant-made vaccines: Indications from a public survey. AgBioForum, 8(4). Available on the World Wide Web: http://www.agbioforum.org.
10. Kitzinger, J. (1995, July 29). Qualitative research: Introducing focus groups. BMJ, 311, 299-302.
11. Kitzinger, J., & Barbour, R. (1999). Introduction: The challenge and promise of focus groups. In J. Kitzinger & R. Barbour (Eds.), Developing focus group research: Politics, theory and practice. London: Sage Publications Ltd.
12. Knight, A.J. (2006). Does application matter? An examination of public perception of agricultural biotechnology applications. AgBioForum, 9(2), 121-128. Available on the World Wide Web: http://www.agbioforum.org.
13. Ma, J.K., Barros, E., Bock, R., Christou, P., Dale, P.J., et al. (2005, July). Molecular farming for new drugs and vaccines. EMBO Rep, 6(7), 593-599. doi: 10.1038/sj.embor. 7400470
14. Ma, J.K., Chikwamba, R., Sparrow, P., Fischer, R., Mahoney, R., & Twyman, R.M. (2005). Plant-derived pharmaceuticals-The road forward. Trends in Plant Science, 10(12), 580-585.
15. Ma, J.K., Drake, P.M., & Christou, P. (2003). The production of recombinant pharmaceutical proteins in plants. Nature Reviews Genetics, 4, 794-805.
16. Marris, C, Wynne, B., Simmons, P., & Weldon, S. (2001). Public perceptions of agricultural biotechnologies in Europe: Final report of the PABE research project. Lancaster, UK: University of Lancaster.
17. Mascia, P.N., & Flavell, R.B. (2004). Safe and acceptable strategies for producing foreign molecules in plants. Current Opinions in Plant Biology, 7, 189-95.
18. Miller, H.I., & Conko, G. (2004). The frankenfood myth: How protest and politics threaten the biotech revolution. Westport, CT: Praeger Publishers.
19. th International Consortium of Agricultural Biotechnology Research (ICABR) annual meeting, Ravello, Italy.
20. Morgan, D.L. (1997). Focus groups as qualitative research. London: Sage Publications Ltd.
21. Nevitt, J., Mills, B.F., Reaves, D.W, & Norton, GW (2006). Public perceptions of tobacco biopharming. AgBioForum, 9(2), 104-110. Available on the World Wide Web: http://www.agbioforum.org.
22. Nevitt, J., Norton, GW, Mills, B.F., Jones, M.E., Ellerbrock, M.J., et al. (2003, April). Participatory assessment of social and economic effects of using transgenic tobacco to produce pharmaceuticals (Participatory Assessment of Social and Economic Impacts of Biotechnology Working Paper No. 01). Blacksburg, VA: Virginia Tech University.
23. Peterson, R., & Arntzen, C. (2004). On risk and plant-based biopharmaceuticals. Trends in Biotechnology, 22(2), 64-66.
24. Pew Initiative on Food and Biotechnology Polls. (2001) The gene is out of the bottle: Where to next? Washington, DC.
25. Spok, A. (2007). Molecular farming on the rise-GMO regulators still walking a tightrope. Trends in Biotechnology, 25(2), 74-82.
26. Walsh, G (2003). Pharmaceutical biotechnology products approved within the European Union. European Journal of Pharmaceutics and Biopharmaceutics, 55(1), 3-10.
27. Wilsdon, J., & Willis, R. (2004). See-through Science: Why public engagement needs to move upstream. London: Demos.